Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss

Cardiovasc Diabetol. 2015 Aug 22:14:113. doi: 10.1186/s12933-015-0276-2.

Abstract

Background: The hyperinsulinemia of obesity is a function of both increased pancreatic insulin secretion and decreased insulin clearance, and contributes to cardiovascular risk. Whilst weight loss is known to enhance insulin clearance, there is a paucity of data concerning the underlying mechanisms. This study was conducted to examine the inter-relationships between changes in sympathetic nervous system (SNS) activity, vascular function and insulin clearance during a weight loss program.

Methods: Seventeen non-smoking, un-medicated individuals aged 55 ± 1 years (mean ± SEM), body mass index (BMI) 33.9 ± 1.7 kg/m(2), underwent a 4-month hypocaloric diet (HCD), using a modified Dietary Approaches to Stop Hypertension diet, whilst seventeen age- and BMI-matched subjects acted as controls. Insulin sensitivity and insulin clearance were assessed via euglycemic hyperinsulinemic clamp (exogenous insulin clearance); hepatic insulin extraction was calculated as fasting C-peptide to insulin ratio (endogenous insulin clearance); SNS activity was quantified by microneurographic nerve recordings of muscle sympathetic nerve activity (MSNA) and whole-body norepinephrine kinetics; and vascular function by calf venous occlusion plethysmography and finger arterial tonometry.

Results: Weight loss averaged -8.3 ± 0.6% of body weight in the HCD group and was accompanied by increased clamp-derived glucose utilization (by 20 ± 9%, P = 0.04) and exogenous insulin clearance (by 12 ± 5%, P = 0.02). Hepatic insulin extraction increased from 6.3 ± 0.8 to 7.1 ± 0.9 (P = 0.09). Arterial norepinephrine concentration decreased by -12 ± 5%, whole-body norepinephrine spillover rate by -14 ± 8%, and MSNA by -9 ± 5 bursts per 100 heartbeats in the HCD group (P all >0.05 versus control group). Step-wise regression analysis revealed a bidirectional relationship between enhanced exogenous insulin clearance post weight loss and reduction in calf vascular resistance (r = -0.63, P = 0.01) which explained 40% of the variance. Increase in hepatic insulin extraction was predicted by enhanced finger reactive hyperaemic response (P = 0.006) and improvement in oral glucose tolerance (P = 0.002) which together explained 64% of the variance.

Conclusions: Insulin clearance is independently and reciprocally associated with changes in vascular function during weight loss intervention. Trial registration ClinicalTrials.gov: NCT01771042 and NCT00408850.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Body Mass Index
  • C-Peptide / blood
  • Caloric Restriction*
  • Female
  • Fingers / blood supply*
  • Glucose Clamp Technique
  • Glucose Tolerance Test
  • Humans
  • Hyperinsulinism / blood
  • Hyperinsulinism / diagnosis
  • Hyperinsulinism / diet therapy*
  • Hyperinsulinism / etiology
  • Hyperinsulinism / physiopathology
  • Insulin / blood*
  • Kinetics
  • Liver / metabolism*
  • Male
  • Manometry
  • Middle Aged
  • Muscle, Skeletal / innervation
  • Norepinephrine / blood
  • Obesity / blood
  • Obesity / complications
  • Obesity / diagnosis
  • Obesity / diet therapy*
  • Obesity / physiopathology
  • Plethysmography
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiopathology
  • Treatment Outcome
  • Vascular Resistance*
  • Victoria
  • Weight Loss*

Substances

  • Biomarkers
  • Blood Glucose
  • C-Peptide
  • Insulin
  • Norepinephrine

Associated data

  • ClinicalTrials.gov/NCT00408850
  • ClinicalTrials.gov/NCT01771042